SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Zentalis Pharmaceuticals presented Phase 1b MUIR trial results showing 39% overall response rate and 7.3-month median PFS for azenosertib combined wit...
Immix Biopharma is conducting an underwritten public offering of approximately 16.8 million shares of common stock at $0.01 per share with Morgan Stan...
Conduent has agreed to sell its Public Transit business to Modaxo for $164 million, expected to close before end of 2026. The divestiture is part of C...
Talen Energy Supply refinanced its credit facility through Amendment No. 6 with a consortium of major banks as lead arrangers. The amendment modifies ...
Radian Group Inc. has entered into an employment agreement with Michael Weinbach to serve as Chief Executive Officer, with an initial term through Dec...
Daktronics extended a consulting agreement with Carla Gatzke through August 28, 2026, reducing the monthly fee to $7,500 for project-specific advisory...
Veritone, Inc. entered into a sales agreement with three underwriters to offer shares of common stock on an at-the-market basis. The offering provides...
Cyngn achieved record expansion with autonomous missions completed surging 127% year-over-year and autonomous driving time up 60% in Q1 2026, driven b...
Portillo's Hot Dogs has engaged Pamela F. Smith as Interim Chief Financial Officer through a consulting agreement effective May 20, 2026, at $728,000 ...
NKGen Biotech and its operating subsidiary amended their secured convertible loan agreement to receive an additional $412,500 in funding from AlpineBr...
Black Diamond Therapeutics announced positive Phase 2 results for silevertinib showing 15.2 months median PFS and 86% CNS ORR in frontline NSCLC patie...
SharonAI Holdings Inc. executed an indenture for convertible senior notes with a 6.00% coupon maturing in 2031, with U.S. Bank Trust Company as truste...
GSR V's May 15, 2026 balance sheet reveals substantial doubt about the company's ability to continue as a going concern due to limited cash and signif...
Whitehawk Therapeutics entered into an option agreement with Hangzhou DAC for access to CPT113 for up to five additional ADC programs, with anticipate...
Sensei Biotherapeutics completed the acquisition of Faeth Therapeutics on February 17, 2026, issuing 10.5M Series B Preferred shares to Faeth sharehol...
Relay Therapeutics launched an underwritten public offering of approximately 22.9 million shares of common stock with an option for underwriters to pu...
SEACOR Marine Holdings obtained lender consent to release $13.7 million from escrow and cancelled all undrawn Tranche B commitments under its November...
GCI Liberty submitted an exhibit filing with the Nevada Secretary of State regarding corporate governance documentation. The filing appears to be a ro...
WhiteFiber secured a five-year, $160 million AI infrastructure agreement with an investment-grade customer in Paris, deploying NVIDIA GPU systems star...
Zelenectide pevedotin combined with pembrolizumab demonstrated response rates comparable to standard of care in metastatic urothelial cancer with appr...